Sedare Biosciences
Sedare Biosciences is a startup headquartered in Palo Alto, United States, founded in 2023. It has raised at least $2.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Sedare Biosciences has raised at least $2.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Sedare Biosciences sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Palo Alto
- Aionics Holdings
- AirNexis Therapeutics
- AkashX
- Aptos Labs
- Aria Networks
- Armadin
- Augment Computing
- Auxia
- BigPanda
- Branch Metrics
- CarbonDrop
Related
- Innovation profile of Palo Alto
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Sedare Biosciences do?
Sedare Biosciences is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Sedare Biosciences raised?
At least $2.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Sedare Biosciences based?
Sedare Biosciences is headquartered in Palo Alto, United States.
When was Sedare Biosciences founded?
Sedare Biosciences was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.